Yahoo
HKSE - Delayed Quote HKD

Asymchem Laboratories (Tianjin) Co., Ltd. (6821.HK)

108.400 +4.500 (+4.33%)
As of 2:40:56 PM GMT+8. Market Open.
View in AlphaSpace Currency in CNY All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
7,435,237.342
6,670,181.013
5,804,657.337
7,825,190.298
10,255,325.393
Cost of Revenue
4,339,889.834
3,869,300.580
3,345,829.993
3,821,800.293
5,397,598.115
Gross Profit
3,095,347.508
2,800,880.433
2,458,827.344
4,003,390.005
4,857,727.278
Operating Expense
1,585,863.232
1,546,765.892
1,756,553.128
1,707,926.257
1,685,614.370
Operating Income
1,509,484.277
1,254,114.541
702,274.216
2,295,463.748
3,172,112.908
Net Non Operating Interest Income Expense
-76,115.161
189,425.795
200,317.208
153,816.354
65,440.786
Pretax Income
1,323,964.225
1,286,385.273
1,072,381.620
2,557,129.702
3,724,944.188
Tax Provision
146,668.518
159,743.235
136,625.456
306,310.300
430,313.640
Net Income Common Stockholders
1,184,509.311
1,132,569.776
948,950.036
2,268,810.444
3,301,635.020
Basic EPS
3.34
3.16
2.69
6.26
9.02
Diluted EPS
3.34
3.16
2.69
6.26
9.00
Basic Average Shares
353,915.861
358,408.157
352,769.530
362,429.783
366,034.925
Diluted Average Shares
353,915.861
358,408.157
352,769.530
362,429.783
366,848.336
Total Operating Income as Reported
1,319,297.173
1,297,369.702
1,078,670.310
2,570,792.245
3,730,780.159
Rent Expense Supplemental
--
1,400.960
1,593.578
1,072.753
0
Total Expenses
5,925,753.065
5,416,066.472
5,102,383.121
5,529,726.550
7,083,212.485
Net Income from Continuing & Discontinued Operation
1,184,509.311
1,132,569.776
948,950.036
2,268,810.444
3,301,635.020
Normalized Income
1,332,581.402
1,230,159.503
981,163.116
2,278,201.739
3,254,207.641
Interest Income
149,828.994
202,967.117
210,401.127
160,138.114
76,624.943
Interest Expense
14,388.191
12,750.755
9,505.251
5,911.681
10,529.441
Net Interest Income
-76,115.161
189,425.795
200,317.208
153,816.354
65,440.786
EBIT
1,338,352.416
1,299,136.028
1,081,886.872
2,563,041.383
3,735,473.629
EBITDA
1,338,352.416
1,849,986.113
1,584,398.940
3,026,983.844
4,077,210.008
Reconciled Cost of Revenue
4,339,889.834
3,869,300.580
3,345,829.993
3,821,800.293
5,397,598.115
Reconciled Depreciation
522,518.921
550,850.085
502,512.068
463,942.461
341,736.379
Net Income from Continuing Operation Net Minority Interest
1,184,509.311
1,132,569.776
948,950.036
2,268,810.444
3,301,635.020
Total Unusual Items Excluding Goodwill
-166,519.040
-111,426.686
-36,916.364
-10,669.340
53,621.897
Total Unusual Items
-166,519.040
-111,426.686
-36,916.364
-10,669.340
53,621.897
Normalized EBITDA
1,504,871.456
1,961,412.799
1,621,315.303
3,037,653.184
4,023,588.111
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-18,446.949
-13,836.958
-4,703.284
-1,278.046
6,194.518
12/31/2022 - 12/10/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: